Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods episode artwork

EPISODE · Jan 2, 2019 · 12 MIN

Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods

from Clinical Chemistry Podcast · host Blithe, Diana

The unintended pregnancy rate in the United States is approximately 45% despite of variety of contraceptive options available to women.  Today, male condoms and withdrawal are the only reversible contraceptive methods available to men with typical failure rates between 10% and 20%.  But what about a male contraceptive pill?  Studies indicate that more than half of men would be interested in using a reversible method if it was available.  And many women would be willing to rely on their partner to use such a contraceptive.  Unplanned pregnancy rates could improve if both partners use a contraceptive method or if men had more options to control their own fertility. The January 2019 issue of Clinical Chemistry is devoted to topics of men's health.  And in that issue, an article examined developments in male contraceptives with an update on both novel hormonal and non-hormonal methods.

Episode metadata supplied by the publisher feed · Published Jan 2, 2019

Embed this episode

NOW PLAYING

Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods

0:00 12:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Chemistry Podcast?

This episode is 12 minutes long.

When was this Clinical Chemistry Podcast episode published?

This episode was published on January 2, 2019.

Can I download this Clinical Chemistry Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!